{
    "title": "Merck buys rights to NewLink's experimental Ebola vaccine",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2847513/Merck-buys-rights-NewLinks-experimental-Ebola-vaccine.html",
    "date": "2014-11-24",
    "keywords": [
        "vaccine",
        "health",
        "ebola",
        "newlink",
        "monday",
        "latestage",
        "year",
        "drugmaker",
        "production",
        "merck",
        "company",
        "institute",
        "percent",
        "gmt",
        "november",
        "email",
        "ransdell",
        "piersonnov",
        "inc",
        "virusnewlink",
        "subsidiary",
        "rvsvebov",
        "mercklarge",
        "product",
        "vaccinesmerck",
        "development",
        "agency",
        "canada",
        "deal",
        "biotechnology",
        "yearit",
        "outbreak",
        "record",
        "guinea",
        "leone",
        "liberia",
        "account",
        "deathsthe",
        "walter",
        "research",
        "allergy",
        "part",
        "institutes",
        "immune",
        "phase",
        "world",
        "organization",
        "earlystage",
        "switzerland",
        "germany",
        "kenya",
        "gabonin",
        "filing",
        "morning",
        "trading",
        "glaxosmithkline",
        "plc",
        "nih",
        "stockpile",
        "emergency",
        "deployment",
        "reporting",
        "vidya",
        "l",
        "nathan",
        "bangalore",
        "editing",
        "von",
        "ahn",
        "cavale"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}